PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCER
Autor: | T.T.T. Nguyen, R. Yagudina, A.U. Kulikov |
---|---|
Rok vydání: | 2011 |
Předmět: |
Oncology
medicine.medical_specialty business.industry Cost effectiveness medicine.medical_treatment Health Policy Public Health Environmental and Occupational Health Trastuzumab HER2 Positive Breast Cancer Internal medicine medicine Stage (cooking) business skin and connective tissue diseases Adjuvant health care economics and organizations medicine.drug |
Zdroj: | Value in Health. 14(3) |
ISSN: | 1098-3015 |
DOI: | 10.1016/j.jval.2011.02.916 |
Databáze: | OpenAIRE |
Externí odkaz: |